Literature DB >> 27401689

Pragmatic Trials in Maintenance Dialysis: Perspectives from the Kidney Health Initiative.

Laura M Dember1, Patrick Archdeacon2, Mahesh Krishnan3, Eduardo Lacson4, Shari M Ling5, Prabir Roy-Chaudhury6, Kimberly A Smith7, Michael F Flessner8.   

Abstract

Pragmatic clinical trials are conducted under the real-world conditions of clinical care delivery. As a result, these trials yield findings that are highly generalizable to the nonresearch setting, identify interventions that are readily translatable into clinical practice, and cost less than trials that require extensive research infrastructures. Maintenance dialysis is a setting especially well suited for pragmatic trials because of inherently frequent and predictable patient encounters, highly granular and uniform data collection, use of electronic data systems, and delivery of care by a small number of provider organizations to approximately 90% of patients nationally. Recognizing the potential for pragmatic trials to generate much needed evidence to guide the care of patients receiving maintenance dialysis, the Kidney Health Initiative assembled a group of individuals with relevant expertise from academia, industry, and government to provide the nephrology community with information about the design and conduct of such trials, with a specific focus on the dialysis setting. Here, we review this information, and where applicable, use experience from the ongoing Time to Reduce Mortality in End Stage Renal Disease Trial, a large cluster-randomized, pragmatic trial evaluating hemodialysis session duration, to illustrate challenges and solutions to operational, ethical, and regulatory issues.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  cluster randomization; electronic medical record; ethical and regulatory issues; health systems; informed consent

Mesh:

Year:  2016        PMID: 27401689      PMCID: PMC5042681          DOI: 10.1681/ASN.2016030340

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  39 in total

1.  Considerations in the evaluation and determination of minimal risk in pragmatic clinical trials.

Authors:  John D Lantos; David Wendler; Edward Septimus; Sarita Wahba; Rosemary Madigan; Geraldine Bliss
Journal:  Clin Trials       Date:  2015-09-15       Impact factor: 2.486

2.  A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers.

Authors:  Kevin E Thorpe; Merrick Zwarenstein; Andrew D Oxman; Shaun Treweek; Curt D Furberg; Douglas G Altman; Sean Tunis; Eduardo Bergel; Ian Harvey; David J Magid; Kalipso Chalkidou
Journal:  J Clin Epidemiol       Date:  2009-05       Impact factor: 6.437

3.  In data we trust: the role and utility of dialysis provider databases in the policy process.

Authors:  Mahesh Krishnan; Helen M Wilfehrt; Eduardo Lacson
Journal:  Clin J Am Soc Nephrol       Date:  2012-09-13       Impact factor: 8.237

4.  Data monitoring committees for pragmatic clinical trials.

Authors:  Susan S Ellenberg; Richard Culbertson; Daniel L Gillen; Steven Goodman; Suzanne Schrandt; Maryan Zirkle
Journal:  Clin Trials       Date:  2015-09-15       Impact factor: 2.486

5.  Lessons learned during the conduct of clinical studies in the dental PBRN.

Authors:  Gregg H Gilbert; Joshua S Richman; Valeria V Gordan; D Brad Rindal; Jeffrey L Fellows; Paul L Benjamin; Martha Wallace-Dawson; O Dale Williams
Journal:  J Dent Educ       Date:  2011-04       Impact factor: 2.264

6.  Guiding principles and checklist for population-based quality metrics.

Authors:  Mahesh Krishnan; Steven M Brunelli; Franklin W Maddux; Thomas F Parker; Douglas Johnson; Allen R Nissenson; Allan Collins; Eduardo Lacson
Journal:  Clin J Am Soc Nephrol       Date:  2014-02-20       Impact factor: 8.237

7.  Navigating the institutional review board approval process in a multicenter observational critical care study.

Authors:  Carmen C Polito; Sushma K Cribbs; Greg S Martin; Terence O'Keeffe; Dan Herr; Todd W Rice; Jonathan E Sevransky
Journal:  Crit Care Med       Date:  2014-05       Impact factor: 7.598

8.  Medical schools' attitudes and perceptions regarding the use of central institutional review boards.

Authors:  Evangeline D Loh; Roger E Meyer
Journal:  Acad Med       Date:  2004-07       Impact factor: 6.893

9.  Variability in IRBs regarding parental acceptance of passive consent.

Authors:  Renee A Higgerson; Lauren E W Olsho; LeeAnn M Christie; Kyle Rehder; Teresa Doksum; Rainer Gedeit; John S Giuliano; Beth Brennan; Rachael Wendlandt; Adrienne G Randolph
Journal:  Pediatrics       Date:  2014-07-07       Impact factor: 7.124

Review 10.  Targets, trends, excesses, and deficiencies: refocusing clinical investigation to improve patient outcomes.

Authors:  Adeera Levin; William Lancashire; Robert G Fassett
Journal:  Kidney Int       Date:  2013-03-20       Impact factor: 10.612

View more
  18 in total

1.  Pragmatic Randomized, Controlled Trial of Patient Navigators and Enhanced Personal Health Records in CKD.

Authors:  Sankar D Navaneethan; Stacey E Jolly; Jesse D Schold; Susana Arrigain; Georges Nakhoul; Victoria Konig; Jennifer Hyland; Yvette K Burrucker; Priscilla Davis Dann; Barbara H Tucky; John Sharp; Joseph V Nally
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-04       Impact factor: 8.237

Review 2.  Ethical Issues in Pragmatic Cluster-Randomized Trials in Dialysis Facilities.

Authors:  Cory E Goldstein; Charles Weijer; Monica Taljaard; Ahmed A Al-Jaishi; Erika Basile; Jamie Brehaut; Charles L Cook; Jeremy M Grimshaw; Eduardo Lacson; Craig Lindsay; Meg Jardine; Laura M Dember; Amit X Garg
Journal:  Am J Kidney Dis       Date:  2019-06-19       Impact factor: 8.860

3.  Cultivating a Research-Ready Dialysis Community.

Authors:  Jennifer E Flythe; Julia H Narendra; Tandrea Hilliard; Karen Frazier; Kourtney Ikeler; Andrew Amolegbe; Denise Mitchell; Adeline Dorough; Shoou-Yih Daniel Lee; Antoinette Ordish; Caroline Wilkie; Laura M Dember
Journal:  J Am Soc Nephrol       Date:  2019-02-08       Impact factor: 10.121

4.  A Pragmatic Step Forward: AKI and Beyond.

Authors:  Laura M Dember
Journal:  J Am Soc Nephrol       Date:  2019-02-21       Impact factor: 10.121

5.  Complementary Initiatives from the NIDDK to Advance Kidney Health.

Authors:  Jenna M Norton; Christian J Ketchum; Andrew S Narva; Robert A Star; Griffin P Rodgers
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-17       Impact factor: 8.237

6.  Pragmatic, Precision Medicine Approaches for Dialysis Vascular Access Dysfunction: Challenges and Opportunities.

Authors:  Prabir Roy-Chaudhury
Journal:  Clin J Am Soc Nephrol       Date:  2016-08-30       Impact factor: 8.237

7.  Perspectives on Research Participation and Facilitation Among Dialysis Patients, Clinic Personnel, and Medical Providers: A Focus Group Study.

Authors:  Jennifer E Flythe; Julia H Narendra; Adeline Dorough; Jonathan Oberlander; Antoinette Ordish; Caroline Wilkie; Laura M Dember
Journal:  Am J Kidney Dis       Date:  2017-12-27       Impact factor: 8.860

8.  Research Priorities for Palliative Care for Older Adults with Advanced Chronic Kidney Disease.

Authors:  Ann M O'Hare; Mi-Kyung Song; Manjula Kurella Tamura; Alvin H Moss
Journal:  J Palliat Med       Date:  2017-05       Impact factor: 2.947

Review 9.  Pragmatic clinical trials offer unique opportunities for disseminating, implementing, and sustaining evidence-based practices into clinical care: Proceedings of a workshop.

Authors:  Leah Tuzzio; Eric B Larson; David A Chambers; Gloria D Coronado; Lesley H Curtis; Wendy J Weber; Douglas F Zatzick; Catherine M Meyers
Journal:  Healthc (Amst)       Date:  2018-12-26

Review 10.  Kidney disease trials for the 21st century: innovations in design and conduct.

Authors:  William G Herrington; Natalie Staplin; Richard Haynes
Journal:  Nat Rev Nephrol       Date:  2019-10-31       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.